This post was originally published on this site
By Cecilia Butini
Novartis AG on Tuesday posted slightly higher net profit and sales for the first quarter of the year, beating analysts’ expectations, and raised its guidance for the full year.
The Swiss pharma major reported net profit of $2.29 billion, up from $2.22 billion the year prior, and beating a consensus expectation of $2.27 billion….
